{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T19:15:20Z","timestamp":1769022920977,"version":"3.49.0"},"reference-count":36,"publisher":"Spandidos Publications","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.3892\/or.2014.3544","type":"journal-article","created":{"date-parts":[[2014,10,13]],"date-time":"2014-10-13T13:06:44Z","timestamp":1413205604000},"page":"2335-2342","source":"Crossref","is-referenced-by-count":24,"title":["Suppression of mucin 2 promotes interleukin-6 secretion and tumor growth in an orthotopic immune-competent colon cancer animal model"],"prefix":"10.3892","volume":"32","author":[{"given":"YAN-SHEN","family":"SHAN","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HUI-PING","family":"HSU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MING-DERG","family":"LAI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MENG-CHI","family":"YEN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JUNG-HUA","family":"FANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TZU-YANG","family":"WENG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YI-LING","family":"CHEN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2014,10,13]]},"reference":[{"key":"key20180107210453_b1-or-32-06-2335","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/(SICI)1096-9896(199708)182:4<385::AID-PATH861>3.0.CO;2-Q","article-title":"Overexpression or ectopic expression of MUC2 is the common property of mucinous carcinomas of the colon, pancreas, breast, and ovary","volume":"182","author":"Hanski","year":"1997","journal-title":"J Pathol"},{"key":"key20180107210453_b2-or-32-06-2335","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1126\/science.1069094","article-title":"Colorectal cancer in mice genetically deficient in the mucin Muc2","volume":"295","author":"Velcich","year":"2002","journal-title":"Science"},{"key":"key20180107210453_b3-or-32-06-2335","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","article-title":"Inflammation and cancer","volume":"420","author":"Coussens","year":"2002","journal-title":"Nature"},{"key":"key20180107210453_b4-or-32-06-2335","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/00002371-199901000-00004","article-title":"Local expression of cytokines in human colorectal carcinoma: evidence of specific interleukin-6 gene expression","volume":"22","author":"Piancatelli","year":"1999","journal-title":"J Immunother"},{"key":"key20180107210453_b5-or-32-06-2335","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/(SICI)1097-0215(19990517)81:4<629::AID-IJC20>3.0.CO;2-8","article-title":"Immunomodulatory effects of tumor-associated fibroblasts in colorectal-tumor development","volume":"81","author":"Lieubeau","year":"1999","journal-title":"Int J Cancer"},{"key":"key20180107210453_b6-or-32-06-2335","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/S0002-9440(10)63067-2","article-title":"Interleukin-6 is an autocrine growth factor in human prostate cancer","volume":"159","author":"Giri","year":"2001","journal-title":"Am J Pathol"},{"key":"key20180107210453_b7-or-32-06-2335","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0022-5347(01)62092-5","article-title":"Elevated levels of circulating interleukin-6 and transforming growth factor-beta 1 in patients with metastatic prostatic carcinoma","volume":"161","author":"Adler","year":"1999","journal-title":"J Urol"},{"key":"key20180107210453_b8-or-32-06-2335","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.canlet.2005.12.003","article-title":"Interleukin-6 level in patients with colorectal cancer","volume":"244","author":"Esfandi","year":"2006","journal-title":"Cancer Lett"},{"key":"key20180107210453_b9-or-32-06-2335","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1006\/clim.2001.5163","article-title":"Prognostic significance of circulating IL-10 and IL-6 serum levels in colon cancer patients undergoing surgery","volume":"102","author":"Galizia","year":"2002","journal-title":"Clin Immunol"},{"key":"key20180107210453_b10-or-32-06-2335","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/BF02361238","article-title":"Serum levels of cytokines in patients with colorectal cancer: possible involvement of interleukin-6 and interleukin-8 in hematogenous metastasis","volume":"29","author":"Ueda","year":"1994","journal-title":"J Gastroenterol"},{"key":"key20180107210453_b11-or-32-06-2335","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1002\/(SICI)1097-0142(19990615)85:12<2526::AID-CNCR6>3.0.CO;2-3","article-title":"Serum interleukin-6 level reflects the tumor proliferative activity in patients with colorectal carcinoma","volume":"85","author":"Kinoshita","year":"1999","journal-title":"Cancer"},{"key":"key20180107210453_b12-or-32-06-2335","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/jso.10269","article-title":"Serum interleukin-6 levels reflect the disease status of colorectal cancer","volume":"83","author":"Chung","year":"2003","journal-title":"J Surg Oncol"},{"key":"key20180107210453_b13-or-32-06-2335","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.cellimm.2009.01.001","article-title":"Macrophage-derived interleukin-6 up-regulates MUC1, but down-regulates MUC2 expression in the human colon cancer HT-29 cell line","volume":"256","author":"Li","year":"2009","journal-title":"Cell Immunol"},{"key":"key20180107210453_b14-or-32-06-2335","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1158\/0008-5472.CAN-13-2322","article-title":"Inflammation amplifier, a new paradigm in cancer biology","volume":"74","author":"Atsumi","year":"2014","journal-title":"Cancer Res"},{"key":"key20180107210453_b15-or-32-06-2335","doi-asserted-by":"crossref","first-page":"38405","DOI":"10.1074\/jbc.M605035200","article-title":"Inhibition of cell migration by autophosphorylated mammalian sterile 20-like kinase 3 (MST3) involves paxillin and protein-tyrosine phosphatase-PEST","volume":"281","author":"Lu","year":"2006","journal-title":"J Biol Chem"},{"key":"key20180107210453_b16-or-32-06-2335","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/mc.20668","article-title":"Establishment of an orthotopic transplantable gastric cancer animal model for studying the immunological effects of new cancer therapeutic modules","volume":"50","author":"Shan","year":"2011","journal-title":"Mol Carcinog"},{"key":"key20180107210453_b17-or-32-06-2335","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1101\/gad.1549407","article-title":"Oncogenic Ras-induced secretion of IL6 is required for tumorigenesis","volume":"21","author":"Ancrile","year":"2007","journal-title":"Genes Dev"},{"key":"key20180107210453_b18-or-32-06-2335","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ccr.2009.06.017","article-title":"Polarization of tumor-associated neutrophil phenotype by TGF-beta: \u2018N1\u2019 versus \u2018N2\u2019 TAN","volume":"16","author":"Fridlender","year":"2009","journal-title":"Cancer Cell"},{"key":"key20180107210453_b19-or-32-06-2335","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1136\/jcp.49.7.560","article-title":"Significance of MUC1 and MUC2 mucin expression in colorectal cancer","volume":"49","author":"Ajioka","year":"1996","journal-title":"J Clin Pathol"},{"key":"key20180107210453_b20-or-32-06-2335","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/S0046-8177(97)90134-9","article-title":"MUC2 gene expression is found in noninvasive tumors but not in invasive tumors of the pancreas and liver: its close relationship with prognosis of the patients","volume":"28","author":"Yonezawa","year":"1997","journal-title":"Hum Pathol"},{"key":"key20180107210453_b21-or-32-06-2335","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1046\/j.1440-1827.2001.01291.x","article-title":"Expression of MUC1 and MUC2 mucins and relationship with cell proliferative activity in human colorectal neoplasia","volume":"51","author":"Li","year":"2001","journal-title":"Pathol Int"},{"key":"key20180107210453_b22-or-32-06-2335","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1172\/JCI115063","article-title":"Mucin production by human colonic carcinoma cells correlates with their metastatic potential in animal models of colon cancer metastasis","volume":"87","author":"Bresalier","year":"1991","journal-title":"J Clin Invest"},{"key":"key20180107210453_b23-or-32-06-2335","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/ijc.2910590302","article-title":"Expression of MUC2-mucin in colorectal adenomas and carcinomas of different histological types","volume":"59","author":"Blank","year":"1994","journal-title":"Int J Cancer"},{"key":"key20180107210453_b24-or-32-06-2335","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1002\/ijc.26182","article-title":"Lymph node CEA and MUC2 mRNA as useful predictors of outcome in colorectal cancer","volume":"130","author":"Ohlsson","year":"2012","journal-title":"Int J Cancer"},{"key":"key20180107210453_b25-or-32-06-2335","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1245\/s10434-010-1338-z","article-title":"Loss of E-cadherin and MUC2 expressions correlated with poor survival in patients with stages II and III colorectal carcinoma","volume":"18","author":"Kang","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"key20180107210453_b26-or-32-06-2335","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s13277-012-0588-8","article-title":"Loss of MUC2 expression predicts disease recurrence and poor outcome in colorectal carcinoma","volume":"34","author":"Elzagheid","year":"2013","journal-title":"Tumour Biol"},{"key":"key20180107210453_b27-or-32-06-2335","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1053\/j.gastro.2006.04.020","article-title":"Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection","volume":"131","author":"Van der Sluis","year":"2006","journal-title":"Gastroenterology"},{"key":"key20180107210453_b28-or-32-06-2335","first-page":"3219","article-title":"Breast cancer cell-derived cytokines, macrophages and cell adhesion: implications for metastasis","volume":"31","author":"Eichbaum","year":"2011","journal-title":"Anticancer Res"},{"key":"key20180107210453_b29-or-32-06-2335","first-page":"4681","article-title":"Elevated expression of the CC chemokine regulated on activation, normal T cell expressed and secreted (RANTES) in advanced breast carcinoma","volume":"59","author":"Luboshits","year":"1999","journal-title":"Cancer Res"},{"key":"key20180107210453_b30-or-32-06-2335","first-page":"285","article-title":"Correlation of tissue and plasma RANTES levels with disease course in patients with breast or cervical cancer","volume":"7","author":"Niwa","year":"2001","journal-title":"Clin Cancer Res"},{"key":"key20180107210453_b31-or-32-06-2335","first-page":"1427","article-title":"Serum interleukin-6 levels correlate to tumor progression and prognosis in metastatic breast carcinoma","volume":"19","author":"Zhang","year":"1999","journal-title":"Anticancer Res"},{"key":"key20180107210453_b32-or-32-06-2335","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/ijc.10833","article-title":"Circulating interleukin-6 predicts survival in patients with metastatic breast cancer","volume":"103","author":"Salgado","year":"2003","journal-title":"Int J Cancer"},{"key":"key20180107210453_b33-or-32-06-2335","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V74.1.1.1","article-title":"The biology of interleukin-6","volume":"74","author":"Kishimoto","year":"1989","journal-title":"Blood"},{"key":"key20180107210453_b34-or-32-06-2335","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1172\/JCI57158","article-title":"Therapeutic strategies for the clinical blockade of IL-6\/gp130 signaling","volume":"121","author":"Jones","year":"2011","journal-title":"J Clin Invest"},{"key":"key20180107210453_b35-or-32-06-2335","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1158\/1078-0432.CCR-08-1988","article-title":"A novel cancer therapy by skin delivery of indoleamine 2,3-dioxygenase siRNA","volume":"15","author":"Yen","year":"2009","journal-title":"Clin Cancer Res"},{"key":"key20180107210453_b36-or-32-06-2335","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.ymthe.2004.05.015","article-title":"Therapeutic HER2\/Neu DNA vaccine inhibits mouse tumor naturally overexpressing endogenous neu","volume":"10","author":"Lin","year":"2004","journal-title":"Mol Ther"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/or.2014.3544\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,25]],"date-time":"2020-08-25T19:16:54Z","timestamp":1598383014000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2014.3544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,13]]},"references-count":36,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2014,10,13]]},"published-print":{"date-parts":[[2014,12]]}},"alternative-id":["10.3892\/or.2014.3544"],"URL":"https:\/\/doi.org\/10.3892\/or.2014.3544","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,13]]}}}